No abstract available
MeSH terms
-
Androgen Antagonists / therapeutic use*
-
Androgen Receptor Antagonists / therapeutic use
-
Angiotensin-Converting Enzyme 2 / metabolism*
-
COVID-19 / complications
-
COVID-19 / prevention & control*
-
Cardiovascular Diseases / etiology
-
Humans
-
Hypoxia / etiology
-
Male
-
Oligopeptides / therapeutic use
-
Prostatic Neoplasms / drug therapy
-
SARS-CoV-2 / physiology*
-
Serine Endopeptidases / genetics
-
Serine Endopeptidases / metabolism*
-
Systemic Inflammatory Response Syndrome / etiology
-
Systemic Inflammatory Response Syndrome / prevention & control
-
Testosterone / adverse effects
-
Testosterone / deficiency
-
Testosterone / therapeutic use
-
Virus Internalization* / drug effects
Substances
-
Androgen Antagonists
-
Androgen Receptor Antagonists
-
Oligopeptides
-
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
-
Testosterone
-
ACE2 protein, human
-
Angiotensin-Converting Enzyme 2
-
Serine Endopeptidases
-
TMPRSS2 protein, human